Muscular Dystrophy Association: Discovery Research Grants

The Muscular Dystrophy Association is accepting letters of intent to support independent, established investigators to accelerate progress toward understanding and treating muscle disease. Discovery research includes the search for understanding the causes of disease, unraveling pathways involved in disease, identifying novel drug targets, and testing new strategies to treat disease. Award amount is up to $100,000 per year for up to three years. The submission deadline is Dec. 15.

The Office of Corporate and Foundation Relations has identified the following private funding opportunity:

Muscular Dystrophy Association: Discovery Research Grants
http://www.mda.org

The Muscular Dystrophy Association (MDA) is accepting letters of intent to support independent, established investigators to accelerate progress toward understanding and treating muscle disease. Discovery research includes the search for understanding the causes of disease, unraveling pathways involved in disease, identifying novel drug targets, and testing new strategies to treat disease. The goal for discovery research is to form a solid foundation which informs and accelerates all subsequent drug development. Since each rare disease poses unique challenges to therapy development, discovery research may include various types of studies related to the unmet needs of each disorder including the creation of improved disease models, biomarker discovery, and the identification of the genetic causes of disease, among others. Eligible applicants must hold an MD, PhD, DSc or equivalent degree; must be a professional or faculty member (professor, associate professor or assistant professor) at an appropriate institution, be qualified to conduct a program of original research within their own laboratory, assume administrative and financial responsibility of the grant and have access to institutional resources necessary to conduct the proposed research project.  Applications should directly relate to a disease in MDA’s program (link here for full list of diseases) and should focus on accelerating therapy development for the disease(s) in question. Indirect cost is limited to 10 percent of all direct costs.

LOI Deadline: Dec. 15, 2016. Invited full applications will be due Jan. 31, 2017. Application Guidelines for the award: https://www.mda.org/sites/default/files/research-grant-app-instructions-06012016.pdf.

The UNC Office of Corporate and Foundation Relations is available to provide assistance in pursuing privately funded opportunities. If you have any questions about this funding opportunity, please email cfr@unc.edu or phone 919-962-2867.

Filed under: